Sign In
Buy TEVA
$32.83
-0.250 (-0.756%)
At Close: Jun 03, 2026
Teva Pharmaceutical Industries Limited (TEVA) CEO Kåre Schultz on Q1 2022 Results - Earnings Call Transcript
12:22pm, Tuesday, 03'rd May 2022
Teva Pharmaceutical Industries Limited (NYSE:TEVA ) Q1 2022 Results Conference Call May 3, 2022 8:00 AM ET Company Participants Ran Meir - Head, IR Kåre Schultz - CEO Eli Kalif - CFO Sven Dethlefs -
Teva Posts Mixed Q1 Earnings, Cuts FY22 Sales Guidance Citing Copaxone Competition, Yet Shares Rise
10:39am, Tuesday, 03'rd May 2022
Teva Pharmaceutical Industries Ltd's (NYSE: TEVA) Q1 sales reached $3.66 billion, shrinking 8% Y/Y, missing the consensus of $3.75 billion. The decrease is mainly due to lower revenues from generi
Teva Pharm Q1 profit down, cuts 2022 revenue outlook
07:33am, Tuesday, 03'rd May 2022
Israel-based Teva Pharmaceutical Industries reported as expected first-quarter profit and trimmed 2022 revenue estimates due to currency fluctuations.
Teva shares slide 3% premarket as company swings to a loss and revenue falls
07:31am, Tuesday, 03'rd May 2022
Teva Pharmaceutical Industries Ltd. shares TEVA, -2.07% slid 3% in premarket trade Tuesday, after the generics company swung to a loss in the first quarter as revenue fell.
Drug/Biotech Stocks Q1 Earnings Due on May 3: PFE, BIIB & More
07:55pm, Monday, 02'nd May 2022 Zacks Investment Research
Let's look at the five biotech/pharma companies, slated to release quarterly results on May 3.
Drug/Biotech Stocks Q1 Earnings Due on May 3: PFE, BIIB & More
05:18pm, Monday, 02'nd May 2022
Let's look at the five biotech/pharma companies, slated to release quarterly results on May 3.
3 No-Brainer Stocks to Buy With $200 During the Market Sell-Off
09:21am, Thursday, 28'th Apr 2022 The Motley Fool
A plunging market is the ideal opportunity to buy these attractively priced stocks.
Walgreens, Teva face San Francisco trial over opioid epidemic
09:08am, Monday, 25'th Apr 2022
San Francisco will square off on Monday against Walgreens Boots Alliance and three other companies accused of fueling an opioid crisis in the city, the first trial to target manufacturers, distributor
Is Teva Pharmaceuticals a Brilliant Contrarian Pick?
01:05pm, Thursday, 21'st Apr 2022 The Motley Fool
Investing in this generic drugmaker would be a gamble, but there are reasons why it might be worth a look.
Is Teva Pharmaceuticals a Brilliant Contrarian Pick?
09:05am, Thursday, 21'st Apr 2022
Investing in this generic drugmaker would be a gamble, but there are reasons why it might be worth a look.
Teva's (TEVA) Schizophrenia Drug Gets CRL From the FDA
03:14pm, Wednesday, 20'th Apr 2022 Zacks Investment Research
Teva Pharmaceuticals (TEVA) and partner MedinCell's new drug application for risperidone to treat schizophrenia faces rejection from the FDA.
Teva's (TEVA) Schizophrenia Drug Gets CRL From the FDA
12:47pm, Wednesday, 20'th Apr 2022
Teva Pharmaceuticals (TEVA) and partner MedinCell's new drug application for risperidone to treat schizophrenia faces rejection from the FDA.
FDA Rejects Teva - MedinCell's Schizophrenia Candidate
07:37am, Wednesday, 20'th Apr 2022
Teva Pharmaceutical Industries Ltd's (NYSE: TEVA) U.S. affiliate and MedinCell SA (OTC: MDCLF) have received FDA Complete Response Letter (CRL) regarding TV-46000/mdc-IRM for schizophrenia. The d
3 Reasons To Buy Teva At $10
04:07am, Thursday, 07'th Apr 2022 Seeking Alpha
TEVA stock traded recently at a $10 level not seen since 10/2021. Why might TEVA stock hold the $10 support level and rally from here? Click here to find out.
3 Reasons To Buy Teva At $10
12:07am, Thursday, 07'th Apr 2022
3 Reasons To Buy Teva At $10
